Table 4.
TBSa | BMSib | |||||
---|---|---|---|---|---|---|
Rho | P-value | Shared variance (%) | Rho | P-value | Shared variance (%) | |
BMI (kg/m2) | −0.284 | 0.121 | 8.1 | 0.201 | 0.423 | 4.0 |
BMD (g/cm2) | ||||||
Lumbar spine | 0.495 | 0.004 | 24.5 | −0.091 | 0.720 | 0.8 |
Femoral neck | 0.529 | 0.002 | 28.0 | −0.154 | 0.542 | 2.4 |
Total hip | 0.501 | 0.003 | 25.1 | −0.069 | 0.785 | 0.5 |
Whole body | 0.591 | <0.001 | 34.9 | −0.194 | 0.440 | 3.8 |
TBS | −0.226 | 0.367 | 5.1 | |||
HbA1c (mmol/L) | ||||||
Current | −0.311 | 0.095 | 9.7 | 0.532 | 0.023 | 28.3 |
5-year mean | −0.284 | 0.116 | 8.1 | 0.362 | 0.140 | 13.1 |
Insulin | ||||||
Daily dose (IU) | −0.337 | 0.069 | 11.4 | 0.566 | 0.018 | 32.0 |
HbA1c (mmol/L) current | Duration of disease | |||||
Rho | P-value | Shared variance (%) | Rho | P-value | Shared variance (%) | |
Insulin | ||||||
Daily dose (IU) | 0.399 | 0.032 | 15.9 | 0.192 | 0.300 | 3.7 |
BMD (g/cm2) | ||||||
Lumbar spine | −0.125 | 0.503 | 1.6 | −0.111 | 0.546 | 1.2 |
Femoral neck | −0.001 | 0.995 | <0.001 | −0.371 | 0.037 | 13.8 |
Total hip | −0.064 | 0.731 | 0.4 | −0.285 | 0.114 | 8.1 |
Whole body | −0.150 | 0.421 | 2.3 | −0.223 | 0.219 | 5.0 |
TBS | −0.311 | 0.095 | 9.7 | −0.299 | 0.103 | 8.9 |
BMSi | 0.532 | 0.023 | 28.3 | 0.367 | 0.147 | 13.5 |
TBSa (n = 33), BMSib (n = 18).
BMD, bone mineral density; BMSi, bone material strength index, TBS, trabecular bone score..